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Abstract
Genome-wide association studies (GWAS) of chronic periodontitis (CP) defined by clinical criteria alone have had modest
success to-date. Here, we refine the CP phenotype by supplementing clinical data with biological intermediates of microbial
burden (levels of eight periodontal pathogens) and local inflammatory response (gingival crevicular fluid IL-1β) and derive
periodontal complex traits (PCTs) via principal component analysis. PCTs were carried forward to GWAS (∼2.5 millionmarkers)
to identify PCT-associated loci among 975 European American adult participants of the Dental ARIC study. We sought to
validate these findings for CP in the larger ARIC cohort (n = 821 participants with severe CP, 2031—moderate CP, 1914—healthy/
mild disease) and an independent German sample including 717 aggressive periodontitis cases and 4210 controls.We identified
six PCTs with distinct microbial community/IL-1β structures, although with overlapping clinical presentations. PCT1
was characterized by a uniformly high pathogen load, whereas PCT3 and PCT5 were dominated by Aggregatibacter
actinomycetemcomitans and Porphyromonas gingivalis, respectively. We detected genome-wide significant signals for PCT1
(CLEC19A, TRA, GGTA2P, TM9SF2, IFI16, RBMS3), PCT4 (HPVC1) and PCT5 (SLC15A4, PKP2, SNRPN). Overall, the highlighted loci
included genes associatedwith immune response and epithelial barrier function.With the exception of associations of BEGAIN
with severe and UBE3D with moderate CP, no other loci were associated with CP in ARIC or aggressive periodontitis in the
German sample. Although not associated with current clinically determined periodontal disease taxonomies, upon replication
and mechanistic validation these candidate loci may highlight dysbiotic microbial community structures and altered
inflammatory/immune responses underlying biological sub-types of CP.
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Introduction
Periodontal disease is a condition that is associated with an exag-
gerated inflammatory response to the oral biofilm. In the absence
of adequate oral hygiene, disease initiates as inflamed gingiva
(gingivitis), but in susceptible individuals it can progress to peri-
odontitis that is characterized by local periodontal tissue destruc-
tion with resorption of alveolar bone, loss of supporting ligament
and tooth loss. Recent studies have shown that periodontal condi-
tions are quite prevalent in humans with approximately 90% of
the US adult population exhibiting at least some form of gingivitis
and 47%of the populationwithperiodontitis; with the severe form
of periodontitis affecting 18% of those individuals over the age of
65 (1,2). Epidemiological studies indicate that poor oral hygiene is
associatedwithmore severe disease, but chronic plaque accrual is
not as strong a predictor of disease in the population as other fac-
tors such as smoking or diabetes (3–5).
Although the oral microbes are believed to be essential to the
causal pathway, theyare not sufficient. Studies in twins suggest a
strong heritability estimate for adult periodontal disease (i.e.
∼50%) and a polygenic predisposition is presumed (6,7). Recent
analyses have indicated that periodontitis is associated with a
shift in the normal human commensal oralmicrobiome resulting
in different microbial colonization patterns that represent dis-
tinct, but stable, dysbiotic communities associated with disease
(8,9). For example, aggressive forms of periodontal disease have
been associated with a biofilm composition which is dominated
by an emergent periodontal pathogen, such as Porphyromonas
gingivalis (10) or Aggregatibacter actinomycetemcomitans (11). These
dysbiotic microbial states are often accompanied with altered
inflammatory signatures and more severe clinical disease. More
prevalent forms of chronic periodontal disease have lower levels
of these twomicroorganismswith clustered combinationof patho-
gens including Treponema denticola (Td), Tannerella forsythia (Tf),
Campylobacter rectus (Cr) and Prevotella nigrescens (Pn) (12). Viral con-
tribution to dysbiosis also seems to be relevant. During periods
of disease exacerbation, there are reported concomitant increases
in the levels of tissue viral expression including Herpes and Cyto-
megalovirus species (13).
Recent genome-wide association studies (GWAS) of chronic
periodontitis (CP) by our and other groups have highlighted loci
potentially associated with clinically derived disease definitions
(14–17) and high levels of specific periodontal pathogens (15,18)
among populations of European descent. No single-marker asso-
ciation in these reports met strict genome-wide significance cri-
teria; however, four loci (NIN/ABHD12B, WHAMM/AP3B2, KCNK1
and DAB2IP) met gene-centric statistical significance criteria,
whereasNPYwas independently reported by two different inves-
tigations (14,19). Taken together, these results underscore the
need to continue exploring for the genetic basis of CP using larger
or pooled samples and high-quality phenotypes.
Conceptually, genetic variants that are causally related to the
clinical manifestation of disease are likely to be associated with
altered biological intermediates or ‘endophenotypes’ which
have the potential to modify host barrier function, inflammatory
responses andmicrobial colonization patterns. In this model, we
suggest that periodontal disease is actually a group of distinct
conditions with similar and overlapping clinical presentations.
Each of these conditions is influenced by human genetic vari-
ation that results in a non-protective inflammatory response
that interacts with the normal commensal biofilm to induce dys-
biotic microbial shifts and clinical disease. We hypothesize that
human genetic variation influences specific dysbiotic shifts in
the oral flora and altered inflammatory signature for each
individual that could provide insight into identifying the genetic
influences on disease expression. There is precedent for this con-
cept. For example, Elinav et al. (20) have demonstrated thatmuta-
tions in the NLRP6 inflammasome complex regulate both the
composition of the colonic microbial ecology, as well as the cyto-
kine and chemokine inflammatory pathways associated with
colitis. In this investigation, we define the disease phenotype as
complex traits using principal component analyses (PCA) to iden-
tify genetic determinants, as described by Suo et al. (21) and
others (22,23). Our PCA models create distinct periodontal com-
plex traits (PCTs) based upon subgingival microbial composition
data and biomarkers of the tissue inflammatory response (IL-1β)
to interrogate in GWA analysis. The intent is to identify loci re-
lated to the biological underpinning and pathogenesis of CP
and not strictly to serve as population markers for clinical CP.
Results
Defining PCTs
The demographic, risk factor and clinical characteristics of the
study participants are presented in Supplementary Material,
Table S1. We used PCA and biological intermediate (microbial
and inflammatory) characteristics to define PCTs for interroga-
tion in GWA analyses, using trait analyses methods described
previously (24,25). PCA was carried out among 975 participants
including microbial (eight pathogens), inflammatory mediator
[gingival crevicular fluid (GCF)-IL1®] and clinical disease classifi-
cation (CDC/AAP chronic periodontitis classification). Using the
three-level CDC/AAP classification there were 394 (40%) subjects
with periodontal health, which includes subjects with gingivitis,
389 (39.9%) subjects with entry-level disease (mild–moderate
periodontitis) and 192 (19.7%) subjects with severe periodontal
disease. Participants had a mean age of 63 years, were approxi-
mately equally distributed by sex, 13% had a history of smoking
and 14% had diabetes mellitus.
The eigenvalues (loadings) for the microbial and inflamma-
tory variables for the first six PCTs (PCT1–PCT6) are presented
in Supplementary Material, Table S2. These six PCTs are shown
selecting those that account for >5% of the variance. The three-
level CDC/AAP disease classification is included as a control vari-
able. Variables with eigenvalues of >0.4 or <−0.4 are generally
considered as significantly contributing to the principal compo-
nent (26,27); the values for each microbial and inflammatory
variable are also shown. Each PCT defines a specific microbial
community structurewith varying levels of IL-1β. The first princi-
pal component, which defines the dominant PCT1 explains 46.5%
of the variance (SupplementaryMaterial, Table S2). PCT2 through
PCT5 each explain about 10% of the variance each with the first
six complex traits together accounting for 90.2% of the total vari-
ance. The remaining five principal components each explain <5%
of the variance, are not associated with clinical disease and have
no significantly associated GWAS loci. However, PCT7 through
PCT11 define five different microbial community structures that
are consistent with health states (data not shown).
Figure 1 shows the principal component profile illustrating
correlations with the constitutive parameters. PCT1 has a micro-
bial community structure that has a high correlation and positive
loading with all pathogens (Supplementary Material, Table S2).
Since these organisms are historically associatedwith themicro-
bial clusters originally identified by Socransky et al. (28), we are
referring to this first PCTas the Socransky Trait. PCT2 is positively
associatedwith severe periodontal disease and hasweak positive
loading of P. gingivalis and IL-1β. PCT3 is characterized by a high
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positive loading of GCF-IL-1β and A. actinomycetemcomitans (Aa
trait) (Fig. 1). PCT4 is associated with a mixed-infection commu-
nity with high positive loading of GCF-IL1®, weak positive load-
ings of Pn, Pi and Td and low levels of Aa. PCT5 has the highest
loading of P. gingivalis across all PCTs with an eigenvalue of
0.882 (Pg trait) followed byA. actinomycetemcomitans (0.134) (Supple-
mentary Material, Table S2) and the correlation with P. gingivalis
can be seen in Figure 1. Notably, no microbial or inflammatory
variables are associated with PCT6, but this trait is positively cor-
related with CDC/AAP entry and severe clinical categories. Com-
plex traits PCT7–PCT11 are associated with health and have
microbial community structures dominated by low counts of
other organisms including P. nigrescens, T. denticola, T. forsythia
and P. intermedia with lower clinical plaque scores (data not
shown).
Associations of PCTs with clinical signs of CP (probing depth,
interproximal attachment level, bleeding on probing, gingival
index, tooth loss and plaque scores) are presented in Table 1.
The clinical signs of periodontal disease, expressed as continuous
variables (extent scores), are significantly associated with the first
six PCTs, asare categorical classifications of disease states. Further
analyses of the subject-level risk factors [sex (female = 0,male = 1),
age, Body mass Index (BMI), smoking (pack/year) and diabetes
(yes = 1, no = 0)] are presented for each PCT inTable 1. Importantly,
the data demonstrate that the PCTs reflect overlapping clinical
presentations and emphasize that the current disease classifica-
tions that are based upon clinical signs display remarkablemicro-
bial and inflammatory heterogeneity. Of note, PCT6 is the trait
most strongly associatedwith clinically determined disease, high-
est plaque levels and highest association with smoking and
diabetes.
Table 2 presents the levels of organisms, concentration of GCF-
IL-1β distribution of CDC/AAP disease categories, total microbial
counts and clinical signs including number of teeth, measures of
interproximal attachment loss (iAL), probing depth (PD), bleeding
on probing (BOP), plaque index scores (PI) and gingival inflamma-
tion scores (GI) stratified by quartiles (Q1–Q4) of each PCT (1–6).
Overall, there is an increase in prevalence in entry and severe dis-
ease with increasing quartiles of PCT and concomitant increases
in clinical signs of disease, although differences in patterns can
be seen. These clinical changes are accompanied by a dysbiotic
shift among the PCTs. For example, within PCT1, comparing
total counts in PCT1–Q1 versus PCT1–Q4 there is a 54-fold increase
in total counts and a 79-fold increase in P. gingivalis. In contrast,
F. nucleatum demonstrates a 1288-fold increase from Q1 to Q4 in
PCT1. Similar significant, but perhaps less dramatic, dysbiotic
Table 1. Correlation matrix (Pearson correlation coefficients and P-values; bold-face indicates statistically significant correlations) of PCTs with
clinical signs of disease and subject characteristics known to modify disease risk
Clinical measures and risk
factor characteristics
PCT1 ‘Socransky trait’ PCT2 PCT3 ‘Aa trait’ PCT4 PCT5 ‘Pg trait’ PCT6
EPDGE4 0.120 0.416 0.211 0.079 0.117 0.492
0.0002 <0.0001 <0.0001 0.0133 0.0002 <0.0001
EALGE3I 0.156 0.314 0.169 0.072 0.123 0.603
<0.0001 <0.0001 <0.0001 0.02 0.0001 <0.0001
EBL 0.198 0.230 0.198 0.093 0.099 0.276
<0.0001 <0.0001 <0.0001 0.0037 0.0019 <0.0001
EGIGE2 0.231 0.164 0.167 0.014 0.078 0.128
<0.0001 <0.0001 <0.0001 0.690 0.0242 0.0002
NTEETH −0.106 0.016 −0.074 −0.043 0.008 −0.046
0.0009 0.625 0.0217 0.178 0.807 0.151
EPQGE1 0.137 0.131 0.149 0.074 0.081 0.240
<0.0001 <0.0001 <0.0001 0.0264 0.0144 <0.0001
Sex 0.021 0.067 0.021 0.004 0.032 0.205
0.513 0.0368 0.515 0.895 0.319 <0.0001
Age 0.039 0.024 −0.044 0.032 0.035 0.127
0.225 0.450 0.170 0.326 0.280 <0.0001
BMI 0.044 0.032 0.065 0.015 0.023 0.067
0.168 0.323 0.0426 0.644 0.465 0.0368
Smoking 0.003 0.078 0.027 0.014 0.021 0.230
0.935 0.0158 0.410 0.677 0.512 <0.0001
Diabetes 0.043 0.070 0.059 0.024 −0.007 0.144
0.183 0.0292 0.0661 0.453 0.838 <0.0001
EPDGE4, extent probing depth ≥4 mm; EALGE3I, extent interproximal clinical attachment loss ≥3 mm; EBL, extent bleeding score; EGIGE2, extent gingival index >1;
Sex (female = 0, male = 1); Age (years); BMI, body mass index; Smoking (pack/years); Diabetes (yes = 1, no = 0).
Figure 1. Principal component trait (PCT) pattern profiles.
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Table 2.Association ofmicrobiological (log-levels of eight periodontal pathogens), inflammatory [log-level of GCF-Interleukin (IL)-1β] and clinical
(CDC/AAP chronic periodontitis classification, number of teeth and ‘extent’ scores) parameters with PCT (defined as quartile-categorical variable)
among the sample of 975 European American participants of the Dental ARIC study
Q1 Q2 Q3 Q4
Mean (SE) or n (%) Mean (SE) or n (%) Mean (SE) or n (%) Mean (SE) or n (%) P-valuea
PCT1 (Socransky trait)
P. gingivalis (Pg) 1.47 (0.10) 1.87 (0.10) 2.24 (0.10) 3.37 (0.10) <0.0001
P. intermedia (Pi) 1.66 (0.12) 2.24 (0.12) 2.58 (0.12) 4.04 (0.12) <0.0001
P. nigrescens (Pn) 1.70 (0.11) 2.26 (0.11) 2.57 (0.11) 4.21 (0.11) <0.0001
T. forsythus (Tf ) 1.30 (0.09) 2.06 (0.09) 2.44 (0.09) 4.01 (0.09) <0.0001
T. denticola (Td) 1.32 (0.10) 2.25 (0.10) 2.63 (0.10) 4.18 (0.10) <0.0001
F. nucleatum (Fn) 1.59 (0.12) 2.43 (0.12) 2.79 (0.12) 4.70 (0.12) <0.0001
C. rectus (Cr) 1.21 (0.09) 2.36 (0.09) 2.84 (0.09) 4.40 (0.09) <0.0001
A. a. 1.33 (0.09) 2.49 (0.09) 2.69 (0.09) 3.97 (0.09) <0.0001
GCF-IL-1β 1.93 (0.02) 2.07 (0.02) 2.13 (0.02) 2.15 (0.02) <0.0001
CDC/AAP Health 101 (25.6) 139 (35.3) 77 (19.5) 77 (19.5)
Entry 142 (36.5) 105 (27.0) 71 (18.3) 71 (18.3)
Severe 0 (0.0) 1 (0.5) 96 (50.0) 95 (49.5) <0.0001
Log total counts 3.80 (0.03) 4.38 (0.03) 4.55 (0.03) 5.53 (0.03) <0.0001
Number of teeth 23.9 (0.43) 22.9 (0.43) 21.8 (0.43) 21.3 (0.43) <0.0001
EALGE3i 16.2 (1.39) 14.3 (1.38) 28.1 (1.38) 30.6 (1.39) <0.0001
EPDGE4 4.01 (0.61) 4.11 (0.61) 9.52 (0.61) 11.1 (0.61) <0.0001
EBL 15.9 (1.38) 19.6 (1.37) 29.3 (1.37) 37.3 (1.38) <0.0001
EPQGE1 26.3 (2.11) 29.4 (2.12) 41.7 (2.15) 54.0 (2.18) <0.0001
EGIGE1 15.2 (2.04) 15.4 (2.08) 27.6 (2.19) 36.8 (2.26) <0.0001
PCT2
P. gingivalis (Pg) 2.14 (0.10) 2.35 (0.10) 1.94 (0.10) 2.52 (0.10) 0.0008
P. intermedia (Pi) 2.70 (0.13) 2.56 (0.13) 2.47 (0.13) 2.79 (0.13) 0.32
P. nigrescens (Pn) 2.76 (0.12) 2.80 (0.12) 2.30 (0.12) 2.89 (0.12) 0.004
T. forsythus (Tf ) 2.41 (0.11) 2.51 (0.11) 2.16 (0.11) 2.73 (0.11) 0.002
T. denticola (Td) 2.58 (0.12) 2.73 (0.12) 2.07 (0.12) 3.01 (0.12) <0.0001
F. nucleatum (Fn) 2.95 (0.14) 3.01 (0.13) 2.41 (0.14) 3.15 (0.14) 0.0006
C. rectus (Cr) 2.73 (0.12) 2.85 (0.12) 2.25 (0.12) 2.98 (0.12) <0.0001
A. a. 2.68 (0.11) 2.69 (0.11) 2.32 (0.11) 2.78 (0.11) 0.01
GCF-IL-1β 1.88 (0.02) 2.06 (0.02) 2.11 (0.02) 2.23 (0.02) <0.0001
CDC/AAP Health 0 (0.0) 100 (25.4) 244 (61.9) 50 (12.7)
Entry 243 (62.5) 145 (37.3) 0 (0.0) 1 (0.3)
Severe 0 (0.0) 0 (0.0) 0 (0.0) 192 (100) <0.0001
Log total counts 4.59 (0.05) 4.59 (0.05) 4.33 (0.05) 4.75 (0.05) <0.0001
Number of teeth 21.9 (0.43) 22.4 (0.43) 23.7 (0.43) 21.9 (0.43) 0.007
EALGE3i 25.0 (1.20) 17.0 (1.20) 5.93 (1.20) 41.3 (1.20) <0.0001
EPDGE4 5.99 (0.55) 5.20 (0.54) 1.53 (0.54) 16.0 (0.55) <0.0001
EBL 23.5 (1.40) 23.2 (1.39) 17.3 (1.39) 37.9 (1.40) <0.0001
EPQGE1 38.7 (2.16) 36.8 (2.15) 24.5 (2.18) 50.6 (2.21) <0.0001
EGIGE1 20.4 (2.13) 21.2 (2.14) 16.6 (2.15) 35.4 (2.28) <0.0001
PCT3 [Aa Trait]
P. gingivalis (Pg) 2.37 (0.11) 2.26 (0.10) 1.97 (0.10) 2.35 (0.11) 0.02
P. intermedia (Pi) 2.66 (0.13) 2.44 (0.13) 2.66 (0.13) 2.75 (0.13) 0.34
P. nigrescens (Pn) 2.55 (0.13) 2.61 (0.12) 2.67 (0.12) 2.91 (0.18) 0.18
T. forsythus (Tf ) 2.58 (0.11) 2.32 (0.11) 2.32 (0.11) 2.59 (0.11) 0.13
T. denticola (Td) 2.47 (0.12) 2.45 (0.12) 2.50 (0.12) 2.97 (0.12) 0.004
F. nucleatum (Fn) 2.77 (0.14) 2.62 (0.14) 2.94 (0.14) 3.19 (0.14) 0.02
C. rectus (Cr) 2.49 (0.12) 2.43 (0.12) 2.82 (0.12) 3.07 (0.12) 0.0002
A. a. 2.46 (0.11) 2.54 (0.11) 2.56 (0.11) 2.91 (0.11) 0.02
GCF-IL-1β 1.71 (0.02) 1.96 (0.02) 2.18 (0.02) 2.42 (0.02) <0.0001
CDC/AAP Health 150 (38.1) 101 (25.6) 79 (20.1) 64 (16.2)
Entry 21 (5.4) 102 (26.2) 133 (34.2) 133 (34.2)
Severe 72 (37.5) 42 (21.9) 32 (16.7) 46 (24.0) <0.0001
Log total counts 4.52 (0.05) 4.52 (0.05) 4.49 (0.05) 4.73 (0.05) 0.004
Number of teeth 22.5 (0.44) 22.5 (0.43) 22.7 (0.44) 22.2 (0.44) 0.88
EALGE3i 20.0 (1.45) 20.9 (1.45) 22.1 (1.45) 26.1 (1.45) 0.02
EPDGE4 5.94 (0.64) 6.41 (0.63) 6.28 (0.63) 10.1 (0.64) <0.0001
EBL 19.2 (1.44) 23.6 (1.43) 25.5 (1.44) 33.6 (1.44) <0.0001
EPQGE1 30.0 (2.19) 35.6 (2.25) 39.6 (2.23) 45.4 (2.24) <0.0001
EGIGE1 20.3 (2.16) 18.5 (2.21) 22.9 (2.20) 30.7 (2.24) 0.0006
Table continues
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Table 2. Continued
Q1 Q2 Q3 Q4
Mean (SE) or n (%) Mean (SE) or n (%) Mean (SE) or n (%) Mean (SE) or n (%) P-valuea
PCT4
P. gingivalis (Pg) 2.67 (0.10) 2.17 (0.10) 1.84 (0.10) 2.26 (0.10) <0.0001
P. intermedia (Pi) 3.24 (0.13) 2.31 (0.13) 2.47 (0.13) 2.50 (0.13) <0.0001
P. nigrescens (Pn) 3.22 (0.12) 2.37 (0.12) 2.43 (0.12) 2.72 (0.12) <0.0001
T. forsythus (Tf ) 3.21 (0.11) 2.34 (0.11) 1.94 (0.11) 2.32 (0.11) <0.0001
T. denticola (Td) 3.26 (0.12) 2.29 (0.12) 2.13 (0.12) 2.71 (0.12) <0.0001
F. nucleatum (Fn) 3.81 (0.13) 2.50 (0.13) 2.47 (0.13) 2.75 (0.13) <0.0001
C. rectus (Cr) 3.58 (0.11) 2.21 (0.11) 2.44 (0.11) 2.59 (0.11) <0.0001
A. a. 3.65 (0.10) 2.36 (0.10) 2.22 (0.10) 2.24 (0.10) <0.0001
GCF-IL-1β 1.78 (0.02) 1.92 (0.02) 2.13 (0.02) 2.44 (0.02) <0.0001
CDC/AAP Health 131 (33.3) 118 (30.0) 74 (18.8) 71 (18.0)
Entry 46 (11.8) 77 (19.8) 139 (35.7) 127 (32.7)
Severe 66 (34.4) 49 (25.5) 32 (16.7) 45 (23.4) <0.0001
Log total counts 5.01 (0.05) 4.36 (0.05) 4.38 (0.05) 4.51 (0.05) <0.0001
Number of teeth 22.1 (0.44) 23.0 (0.43) 22.8 (0.43) 22.0 (0.44) 0.23
EALGE3i 20.2 (1.45) 20.7 (1.45) 22.2 (1.45) 26.0 (1.45) 0.02
EPDGE4 6.43 (0.64) 5.68 (0.64) 7.01 (0.64) 9.59 (0.64) 0.0001
EBL 24.0 (1.45) 20.3 (1.45) 25.9 (1.45) 31.7 (1.45) <0.0001
EPQGE1 37.8 (2.23) 32.1 (2.24) 36.3 (2.23) 44.2 (2.27) 0.002
EGIGE1 23.7 (2.21) 18.7 (2.23) 21.1 (2.17) 28.7 (2.22) 0.01
PCT5 [Pg Trait]
P. gingivalis (Pg) 1.28 (0.09) 2.59 (0.09) 1.80 (0.09) 3.28 (0.09) <0.0001
P. intermedia (Pi) 2.87 (0.13) 2.36 (0.13) 2.57 (0.13) 2.73 (0.13) 0.03
P. nigrescens (Pn) 2.70 (0.12) 2.36 (0.12) 2.67 (0.12) 3.01 (0.12) 0.004
T. forsythus (Tf ) 2.23 (0.11) 2.27 (0.11) 2.31 (0.11) 2.91 (0.11) <0.0001
T. denticola (Td) 2.51 (0.12) 2.31 (0.12) 2.64 (0.12) 2.92 (0.12) 0.003
F. nucleatum (Fn) 2.79 (0.14) 2.58 (0.14) 2.81 (0.14) 3.32 (0.14) 0.001
C. rectus (Cr) 2.51 (0.12) 2.39 (0.12) 2.74 (0.12) 3.16 (0.12) <0.0001
A. a. 2.27 (0.10) 2.60 (0.10) 2.44 (0.10) 3.16 (0.10) <0.0001
GCF-IL-1β 2.00 (0.02) 2.12 (0.02) 2.04 (0.02) 2.11 (0.02) 0.002
CDC/AAP Health 165 (41.9) 170 (43.2) 47 (11.9) 12 (3.1)
Entry 6 (1.5) 1 (0.3) 163 (41.9) 219 (56.3)
Severe 72 (37.5) 73 (38.0) 35 (18.2) 12 (6.3) <0.0001
Log total counts 4.54 (0.05) 4.39 (0.05) 4.52 (0.05) 4.80 (0.05) <0.0001
Number of teeth 23.3 (0.44) 22.6 (0.43) 22.1 (0.43) 21.8 (0.43) 0.07
EALGE3i 19.0 (1.44) 18.3 (1.44) 24.7 (1.44) 27.1 (1.44) <0.0001
EPDGE4 6.66 (0.64) 6.91 (0.64) 7.52 (0.64) 7.61 (0.64) 0.67
EBL 23.2 (1.47) 23.5 (1.47) 26.8 (1.46) 28.5 (1.47) 0.03
EPQGE1 34.0 (2.25) 33.7 (2.25) 38.2 (2.21) 44.5 (2.26) 0.002
EGIGE1 21.3 (2.24) 20.5 (2.26) 23.4 (2.14) 26.8 (2.24) 0.20
PCT6
P. gingivalis (Pg) 2.19 (0.11) 2.41 (0.11) 2.10 (0.11) 2.25 (0.11) 0.19
P. intermedia (Pi) 2.72 (0.13) 2.70 (0.13) 2.42 (0.13) 2.67 (0.13) 0.31
P. nigrescens (Pn) 2.61 (0.12) 2.76 (0.12) 2.63 (0.12) 2.74 (0.12) 0.76
T. forsythus (Tf ) 2.41 (0.11) 2.56 (0.11) 2.22 (0.11) 2.61 (0.11) 0.054
T. denticola (Td) 2.57 (0.12) 2.69 (0.12) 2.54 (0.12) 2.59 (0.12) 0.83
F. nucleatum (Fn) 2.81 (0.14) 3.03 (0.14) 2.79 (0.14) 2.88 (0.14) 0.56
C. rectus (Cr) 2.67 (0.12) 2.75 (0.12) 2.67 (0.12) 2.72 (0.12) 0.95
A. a. 2.56 (0.11) 2.77 (0.11) 2.49 (0.11) 2.65 (0.11) 0.26
GCF-IL-1β 2.25 (0.02) 1.98 (0.02) 2.08 (0.02) 1.97 (0.02) <0.0001
CDC/AAP Health 240 (60.9) 154 (39.1) 0 (0.0) 0 (0.0)
Entry 1 (0.3) 82 (21.1) 240 (61.7) 66 (17.0)
Severe 2 (1.0) 9 (4.7) 3 (1.6) 178 (92.7) <0.0001
Log total counts 4.54 (0.05) 4.65 (0.05) 4.45 (0.05) 4.61 (0.05) 0.05
Number of teeth 22.9 (0.44) 22.6 (0.43) 22.3 (0.44) 22.2 (0.43) 0.70
EALGE3i 6.84 (1.18) 14.7 (1.18) 25.0 (1.18) 42.5 (1.18) <0.0001
EPDGE4 1.94 (0.55) 4.30 (0.55) 6.95 (0.55) 15.5 (0.55) <0.0001
EBL 19.3 (1.43) 22.5 (1.43) 25.8 (1.43) 34.4 (1.43) <0.0001
EPQGE1 28.8 (2.23) 35.6 (2.20) 40.2 (2.20) 46.0 (2.26) <0.0001
EGIGE1 18.6 (2.21) 24.1 (2.18) 22.2 (2.16) 27.5 (2.31) 0.04
Aa, Aggregatibacter actinomycetemcomitans; EALGE3i, extent interproximal attachment loss ≥3 mm; EPDGE4, extent probing depth ≥4 mm; EBL, extent bleeding on probing;
EPQGE1, extent plaque score ≥1; EGIGE1, extent gingival index score ≥1.
Log total counts represent the sum of the specific pathogens identified by whole chromosomal DNA probes for the individual tested species.
aDerived from ANOVA for continuous and χ2 tests for categorical variables.
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shifts illustrate the magnitude of the changes associated with
these traits. For example, there is a 2.8-fold increase in Aa in
PCT3 and a 100-fold increase in Pg in PC5 comparing Q1 versus
Q4, respectively.
Identification of candidate gene loci associated with
complex traits
After applying the exclusion criteria outlined in theMaterials and
Methods section, there remained 2135235 SNPs that were in-
cluded in the GWA analysis. Q–Q plots were generated for each
PCT and the lambda coefficients for all six traits ranged between
0.994 and 1.031, suggesting virtually no genomic inflation after
adjustment for global ancestry. Therewere 69 genome-wide stat-
istically significant SNPs that were below the P-value threshold
5.0 × 10−8, marking 10 loci. There were six loci associated with
the Socransky trait (PCT1), two loci for the Aa trait PCT3, one
locus for PCT4 and three loci associated with the Pg trait (PCT5).
Manhattan plots are presented in Figure 2A–C. Two SNPs within
the Aa trait (PCT3) met genome-wide significance criteria:
rs4074082 (C1QTNF7; MAF = 0.059, P = 2.2 × 10−8) and rs9772881
(FLJ43860; MAF = 0.10, P = 3.1 × 10−8). No genome-wide significant
SNPs were identified for PCT2 or PCT6, which are both associated
with smoking and diabetes, as shown in Table 1. Consistent with
the current recommendations for reporting GWAS findings, we
have made available the entire set of single-marker association
results for the six PCTS listed in ascending P-value order at:
http://genomewide.net/public/aric/dental/complex_traits/pct#.
txt, where # ranges between 1 and 6. The annotations for the sig-
nificant loci for the Socransky trait, the Aa trait, PCT4 and the Pg
trait appear in Table 3. The lowest imputation score was 0.946.
Three loci which emerged as promising candidates are illu-
strated using LocusZoom in Figure 3A–C. Within the Socransky
trait the SNP with the lowest P-value (3.0 × 10−10) is rs1156327
(MAF = 0.192), at 16q11.2 and in moderate proximity to CLEC19A
(C-type lectin domain family 19 member A) (Fig. 3A). This locu-
s includes an additional coding, non-synonymous SNP with
P = 9.7 × 10−8: rs179196 (r2 = 0.34). This missense SNP (MAF = 0.21)
represents a T–G base change resulting an amino acid change of
S→A in protein amino acid position 16 which is located in the
signal peptide region. CLEC19A is a glycoprotein which can be
membrane-tethered or secreted and believed to be involved in
carbohydrate recognition functioning as a pattern recognition re-
ceptor (CLR, C-lectin receptor) for immune signaling, as other
Figure 2. (A) Periodontal Complex Trait 1 (Socransky Trait) Manhattan plot. (B) Periodontal Complex Trait 4 Manhattan plot. (C) Periodontal Complex Trait 5 (Pg Trait)
Manhattan plot.
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members of the CLR protein family. Also associated with the
Socransky Trait (PCT1) is IFI16 (Gamma interferon inducible pro-
tein 16, rs1633266, P = 3.8 × 10−8, MAF = 0.26). IFI16 encodes a pro-
tein that contains two HIN-200 domain and functions as a sensor
of intracellular DNA that stimulates interferon expression and in-
flammasome activation in response to viral challenge (29). The
IFI16 locus appears in Figure 3B and is marked by rs1633266 which
is in linkage disequilibrium with three additional missense SNPs:
rs6940 (r2 = 1.00; P = 2.0 × 10−7), rs1057028 (r2 = 0.70; P = 4.5 × 10−6)
and rs1057027 (r2 = 0.70; P = 4.5 × 10−6). Of those, rs6940 and
rs1057028 are predicted to result in a potentially/probably dam-
aging alteration in the protein structure. Rs6940 shows a dual
amino acid substitution (T–S) at positions 723 and 779 within the
785-amino acid protein (30) while rs1057028 indicates a Y→N at
position 413 and rs1057027 represents a potentially benign substi-
tution (R→S at position 409). The Pg Trait (PCT5) showed a signifi-
cant association with a chromosome 12 locus marked by
rs6488099 (P = 1.1 × 10−8), which is intronic to PKP2 (plakophilin 2,
Fig. 3C). PKP2 is a structural protein present within desmosomal
structures of basal epithelial cells and within the myocardium.
Identification of candidate genes associated with
complex traits
We carried forward the single-marker results to genome-wide
gene-centric association analysis for the first six complex traits
using MAGENTA (15), correcting for gene size (including a
110 kb upstream and the 40 kb downstream region, as employed
in previous investigations) (15,31), the number of SNPswithin the
gene region, and local linkage disequilibrium characteristics (15).
Gene-centric analyses involve a smaller number of tests of asso-
ciation (i.e. genes versus SNPs) and aggregatemultiple signals per
locus, thus offering gains in power to detect candidate genes. We
queried 18 307 genes and used a Bonferroni multiple testing-cor-
rected P-value threshold of 0.05/18307 = 2.7 × 10−6. Eighty genes in
37 loci were found to be significantly associatedwith the complex
traits as shown in Table 4. Significant gene-centric associations
were also found for 5 of the 10 loci identified in Table 3: Socransky
trait—CLEC19A, GGTA2P and IFI16; Aa trait—C1QTNF7; Pg trait—
PKP2 and SNRPN. The full list of gene-centric association testing
results is available at http://genomewide.net/public/aric/dental/
gene-centric/CP_PCT_Genes.xls.
Validation of loci for clinically defined disease
taxonomy and severity
Weexamined the association of all previously highlighted loci with
clinically defined disease in the larger ARIC cohort (n= 4766) and an
independent German sample including 717 aggressive periodon-
titis (AgP) cases and 4210 controls generated by Schaefer et al. and
previously reported (32–36). Overall, we found little evidence of val-
idation for clinically defined CP (moderate versus health and severe
Figure 3. (A) PCT1 locus CLEC19A. (B) PCT1 locus IFI16. (C) PCT1 locus PKP2.
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Table 4. Results of genome-wide gene-centric association analyses for the six PCTs
PCT Chr Gene
P-value
Symbol Entrez Gene Name Top SNP in
region
1 16 8.00E-12 TMC5 Transmembrane Channel-Like 5 rs1156327
1 12 1.47E-09 CAND1 Cullin Associated and Neddylation-Dissociated 1 rs17184007
1 1 4.70E-09 AIM2 Absent in melanoma 2 rs1633266
1 13 1.03E-08 TM9SF2 Transmembrane 9 Superfamily Member 2 rs9557237
1 1 1.16E-08 IFI16 Interferon, Gamma-Inducible Protein 16 rs1633266
1 16 2.35E-08 MLKL Mixed Lineage Kinase Domain-Like rs2240246
1 16 2.46E-08 RFWD3 Ring Finger and WD Repeat Domain 3 rs2240246
1 10 5.48E-08 SMC3 Structural maintenance of chromosomes 3 (bamacan) rs11195183
1 1 8.89E-08 CADM3 Cell Adhesion Molecule 3 rs1633266
1 19 9.19E-08 PLEKHG2 Pleckstrin Homology Domain Containing, Family G
(With RhoGef Domain) Member 2
rs3786949
1 19 9.78E-08 SUPT5H Suppressor Of Ty 5 Homolog (S. cerevisiae) rs3786949
1 10 1.13E-07 DUSP5 Dual specificity phosphatase 5 rs11195183
1 19 1.43E-07 IL28B Interferon, Lambda 3 rs3786949
1 19 1.47E-07 MED29 Mediator Complex Subunit 29 rs3786949
1 19 1.49E-07 GMFG Glia maturation factor, gamma rs3786949
1 19 1.70E-07 ZFP36 ZFP36 Ring Finger Protein rs3786949
1 19 2.19E-07 SAMD4B sterile alpha motif domain containing 4B rs3786949
1 19 3.18E-07 IFNL1 Interferon, lambda 1 (IL29)a rs3786949
1 19 3.40E-07 LRFN1 Leucine rich repeat and fibronectin type III domain containing 1 rs3786949
1 16 3.77E-07 FA2H Fatty acid 2-hydroxylase rs2240246
1 16 5.75E-07 SYT17 Synaptotagmin I rs1156327
1 18 1.05E-06 CBLN2 Cerebellin 2 precursor rs1432076
2 12 5.51E-07 ANKLE2 Ankyrin Repeat and LEM Domain Containing 2 rs10781645
2 1 8.48E-07 DMAP1 DNA Methyltransferase 1 Associated Protein 1 rs4660770
2 1 8.94E-07 KLF17 Kruppel-like factor 17a rs4660770
2 12 1.48E-06 GOLGA3 Golgin A3a rs10781645
2 12 1.61E-06 POLE Polymerase (DNA Directed), Epsilon, Catalytic Subunit rs10781645
2 1 1.80E-06 SLC6A9 Solute Carrier Family 6 (Neurotransmitter Transporter, Glycine), Member 9 rs4660770
3 4 1.53E-08 C1QTNF7 C1q and tumor necrosis factor-related protein 7 rs4074082
3 2 4.74E-08 DGKD Diacylglycerol kinase, delta 130 kDa rs7568534
3 9 7.55E-08 ZNF483 Zinc Finger Protein 483 rs10980953
3 9 1.05E-07 KIAA0368 KIAA0368 rs10980953
3 9 1.60E-07 DNAJC25 DnaJ (Hsp40) Homolog, Subfamily C, Member 25 rs10980953
3 9 2.04E-07 DNAJC25-GNG10 DNAJC25-GNG10 readthrough rs10980953
3 9 2.36E-07 GNG10 Guanine Nucleotide Binding Protein (G Protein), Gamma 10 rs10980953
3 9 2.43E-07 PTGR1 Prostaglandin reductase 1 rs10980953
3 17 2.90E-07 ANKRD40 Ankyrin Repeat Domain 40 rs4148411
3 9 5.47E-07 IFNA14 Interferon, Alpha 14 rs13340713
3 17 5.99E-07 CROP LUC7-Like 3 (S. cerevisiae) rs4148411
3 6 8.28E-07 DAAM2/KIF6 Dishevelled Associated Activator of Morphogenesis 2/Kinesin Family
Member 6
rs9471152
3 9 8.83E-07 IFNA17 Interferon, alpha 17 rs13340713
3 10 9.57E-07 INPP5F inositol polyphosphate-5-phosphatase F rs17680667
3 10 1.06E-06 DUPD1 Dual specificity phosphatase DUPD1a rs2395126
3 17 1.12E-06 ABCC3 ABCC3 protein rs4148411
3 9 1.18E-06 IFNA16 Interferon, Alpha 16 rs13340713
3 10 1.24E-06 SAMD8 Sterile Alpha Motif Domain Containing 8 rs2395126
3 9 1.27E-07 IFNA7 Interferon, Alpha 7 rs13340713
3 6 1.36E-06 REV3L/TRAF3IP2 REV3-Like, Polymerase (DNA Directed), Zeta, Catalytic Subunit/TRAF3
Interacting Protein 2a
rs13196377
3 9 1.38E-06 IFNA10 Interferon, Alpha 10 rs13340713
3 17 1.98E-06 CACNA1G Voltage-dependent T-type calcium channel subunit alpha-1G rs757415
3 10 2.21E-06 SEC23IP SEC23 Interacting Protein rs17680667
3 10 2.35E-06 MCMBP Minichromosome Maintenance Complex Binding Protein rs17680667
3 10 2.57E-06 KAT6B K(Lysine) Acetyltransferase 6B rs2395126
3 9 2.59E-06 IFNA21 Interferon, Alpha 21 rs13340713
4 14 7.43E-09 BEGAIN Brain-enriched guanylate kinase-associated rs7144384
4 14 1.23E-07 DLK1 Delta-like 1 homolog (Drosophila) rs7144384
5 7 1.29E-09 MRPL32 Mitochondrial Ribosomal Protein L32 rs2288354
5 7 3.27E-09 C7orf25 Chromosome 7 Open Reading Frame 25 rs2288354
Table continues
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versus health); the data shown in SupplementaryMaterial, Table S3
are derived fromgene-centric analyses reported by Rhodin et al. (15)
and illustrate that with the exception of associations of BEGAIN
with severe CP (P = 4.3× 10−4) andUBE3D (P = 1.3 × 10−4) withmoder-
ateCP, noother lociwere associatedwithCP inARICafteramultiple
testing correction. Two additional loci met nominal statistical
significance criteria (KLF17—P = 3.0 × 10−2 with moderate CP and
DLK1—P = 2.1 × 10−3 with severe CP). Similarly, no association was
found with AgP (Supplementary Material, Table S4) in the German
sample. No SNP surpassed the multiple testing-corrected signifi-
cance threshold and in fact 27 of 37 loci showed discordant direc-
tionality (binomial test two-tailed P = 0.008).
The nearly complete lack of replication for clinical disease tax-
onomies raises the possibility that these PCTs may have little rele-
vance to clinically defined disease taxonomies, which represent
conglomerates of different pathogenic effector mechanisms. On
the other hand, it is also possible that the identified PCT loci may
beassociatedwith clinical diseaseonly in the contextof specificmi-
crobial community/inflammatory patterns, which reflect biological
sub-types of clinical periodontitis. Some evidence in support of this
notion is illustrated inTable 2,where the PCTs (quartile-categorical)
are generally associated with more severe disease, as defined by
clinical criteria. For this reason, we tested the putative candidate
gene-centric associations (obtained from Tables 3 and 4) with clin-
ical disease severity in the context of each respective PCT (microbial
and inflammatory pattern) via orthogonal analyses (adjusting for
the other PCTs). Since we only tested 80 genes in this manner, we
used a Bonferronimultiple comparison-corrected statistical signifi-
cance threshold of P = 6.2 × 10−4.
Three genes (GOLGA3, KLF17 and IPP5F) were found to be sig-
nificantly associated with clinical disease severity in the context
of their PCT phenotypic environment, while six other loci ap-
proached significance (Table 5). However, these results should be
considered with caution. First, these associations were less pro-
nounced (null, after correction for multiple testing) if considered
outside the context of the biologically informed trait. As shown
in SupplementaryMaterial, Table S5, adjustment ‘endophenotype
context’ (i.e. the other PCTs) resulted in mostly attenuated esti-
mates of association (betas) for the lead SNPs in the nine high-
lighted loci (five out of nine SNPs had smaller estimates of
association) or had no material impact (three out of nine SNPs
with small increases in beta, 11% or less). A substantial increase
in the magnitude of association was noted for only one SNP
(rs4660770; KLF17 locus) which was not associated with the
index PCT in unadjusted analysis (P = 0.5). Moreover, the inclusion
of all other PCTs in themodelsmight raise issues of false positives
due to collinearity. To rule out this possibility, we performed a for-
mal test of covariate collinearity by computing the variance infla-
tion factor (VIF) for themodels used to produce Table 5. The seven
models testedhadVIF values rangingbetween1.02 and 1.18 for the
PCTs entered into each model as covariates, with VIF >10 consid-
ered indicative of serious collinearity. Based on this diagnostic in-
formation, we suggest that there is little evidence of bias due to
collinearity (37). Nonetheless, these results must be interpreted
with caution, and for this reasonwepresent both adjusted andun-
adjusted (for the other PCTs) single-marker association results for
these loci in Supplementary Material, Table S5.
Discussion
We used PCA enriched with biologically informed periodontal
phenotypes to identify six PCTs that are characterized by specific
Table 4. Continued
PCT Chr Gene
P-value
Symbol Entrez Gene Name Top SNP in
region
5 15 3.44E-09 SNURF SNRPN Upstream Reading Frame rs904310
5 12 3.65E-09 PKP2 Plakophilin 2 rs6488099
5 12 5.17E-09 YARS2 Tyrosyl-TRNA Synthetase 2, Mitochondrial rs6488099
5 7 6.66E-09 PSMA2 Proteasome (Prosome, Macropain) Subunit, Alpha Type, 2 rs2288354
5 15 5.18E-08 SNRPN Small Nuclear Ribonucleoprotein Polypeptide N rs904310
5 14 3.82E-07 SEC23A Sec23 homolog A (S. cerevisiae) rs11622736
5 14 4.41E-07 PNN Pinin, desmosome-associated protein rs11622736
5 14 5.10E-07 MIA2 Melanoma Inhibitory Activity 2 rs11622736
5 14 5.14E-07 TRAPPC6B Trafficking Protein Particle Complex 6B rs11622736
5 14 5.23E-07 GEMIN2 Gem (Nuclear Organelle) Associated Protein 2 rs11622736
5 2 6.24E-07 DHX57/MORN2 DEAH (Asp–Glu–Ala–Asp/His) Box Polypeptide 57/MORN Repeat
Containing 2a
rs3099950
5 19 7.36E-07 COLGALT1/
UNC13A
Collagen Beta(1-O)Galactosyltransferase 1/Unc-13
Homolog A (C. Elegans)
rs3746200
5 13 9.12E-07 TEX26-ASI Testis expressed 26 rs12877861
5 13 9.38E-07 MEDAG Mesenteric Estrogen-Dependent Adipogenesis rs12877861
5 14 1.04E-06 CTAGE5 CTAGE Family, Member 5 rs11622736
5 9 1.18E-06 POMT1/UCK1 Protein-O-Mannosyltransferase 1/Uridine–Cytidine Kinase 1a rs2282010
5 16 1.23E-06 KIFC3 Kinesin family member C3 rs12922275
5 1 1.33E-06 HTR1D 5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled rs16828047
5 9 1.43E-06 PRRC2B Proline-rich coiled-coil 2B rs2282010
5 1 1.60E-06 LUZP1 Leucine zipper protein 1 rs9426689
5 16 2.10E-06 KATNB1 Katanin p80 (WD repeat containing) subunit B 1 rs12922275
6 6 1.45E-06 UBE3D Ubiquitin protein ligase E3D rs10484711
Statistically significant genes are shown for all six PCTs identifying chromosomal location, gene symbol andHUGOGeneNameand top SNPwithin region (lowest P-value).
P-values reflect the value for the entire gene, rather than the best SNP.
aCoding, non-synonymous SNPs are within loci for IFNL1, GOLGA3, KLF17, DUPD1, TRAF3IP2, MORN2 and UCK1.
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dysbiotic microbial community structures and inflammatory
mediator levels. The GWAS results reported here were generated
among 975 genotyped with known subgingival microbial plaque
composition and gingival inflammatory response (IL-1β levels)
and provide evidence in support of several novel candidate loci.
The Dental ARIC population currently represents one of the lar-
gest reported samples of community-dwelling subjects with
both full-mouth periodontal clinical examinations and genotype
data. Wewere able to define six microbial/IL1β community struc-
tures as PCTs that are associated with clinical disease and iden-
tified 10 loci and 80 candidate genes possibly associated with
these complex traits. With the exceptions of BEGAIN (severe CP)
andUBE3D (moderate CP) thesewere not associatedwith clinical-
ly defined disease neither in the larger cohort of 4910 Dental ARIC
participants nor in an independent Germandata set of aggressive
periodontitis of 4916 participants (717 cases). The nearly com-
plete lack of replication in the clinically defined disease cohorts
raises the possibility that these PCTsmay be genetically tractable
endophenotypes that nevertheless have little relevance to dis-
ease defined with clinical criteria alone. This suggests that the
six PCTs, although having overlapping clinical presentations,
may actually reflect six different conditions with distinct genetic
risk profiles that may be discoverable only in the context of spe-
cific patterns of microbial dysbiosis and inflammatory response.
One of the consequences of identifying genes for common com-
plex traits is that as sample sizes increase to boost power, so too
does phenotypic heterogeneity (36). The approach considered
here may allow for the identification of meaningful subgroups
of disease pathogenesis, highlighting the role of microbial dys-
biosis and inflammatory response. These loci may help identify
new pathways of pathogenesis which can facilitate the identifi-
cation of complex periodontal traits for the study of genetic
susceptibility.
Genes in loci associated with the Socransky (PCT1), the Aa
(PCT3) and the Pg traits (PCT5) suggest a common biological
underpinning that controls the epithelial, connective tissue and
innate immune response (Fig. 4). These loci, which were high-
lighted by several missense variants, appear to enhance disease
susceptibility in the presence of a dysbiotic microbial structure.
PCT1 explains the greatest variance and has the microbial com-
munity structure associatedwith themost common form of peri-
odontal disease. We refer to this as the Socransky trait, since he
first described the emergence of this microbial pattern of colon-
ization in chronic adult periodontitis against a background of at-
tenuated commensals that are associated with health (28).
CLEC19A has an unknown function, but belongs to a family of
carbohydrate recognition receptors and provides an interesting
new candidate for further study. Interestingly, also within PCT1
two candidate genes, IFI16 and AIM2, are both involved with
the intracellular processing of foreign DNA. IFI16 recognizes for-
eign intracellular DNA and activates type I interferon expression
via the STING pathway and complexes with AIM2 to form an in-
flammasome. AIM2 is also capable of binding foreign DNA and
the complex is a caspase-1/inflammasome activator, triggering
a local IL-1β response. This suggests the possibility that poly-
morphisms in these genes may result in an altered processing
of invasive intracellular oral pathogens, including viruses and
possibly organisms such as Pg, Cr and Aa, which are associated
with the Socransky trait. Dendritic, synaptic or neural proteins
also emerge as amolecular theme for genetic variation in the So-
cransky trait with significant loci identified including CBLN2,
GMFG, LRFN1, FA2H and SAMD4. The theme of neural regulation
of periodontal inflammation has been previously reported from
whole transcriptome analyses (38). ‘Nervous system-signaling’
has also been reported as the most enriched pathway in the
chronic periodontitis GWAS reported by Divaris et al. (14). Inter-
estingly, two genes with missense variants emerge as potential
candidates for PCT2- GOLGA3 and KLF17 (a member of the KLF
transcriptional factor family that regulates epithelial–mesenchy-
mal transition). The Aa trait (PCT3) showed a significant associ-
ation with additional genes including the adipokine C1QTNF7,
another type I interferon IFNA14 and TRAF3IP2. The TRAF3IP2
protein is involved in IL-17 signaling and mucosal immunity
serving as an adaptor protein for the IL-17 receptor. Genetic
variants of TRAF3IP2 have been associated with epithelial dys-
function in psoriasis and inflammatory bowel disease (39,40).
Variants of the neuronal proteins BEGAIN and DLK1 are asso-
ciated with PCT4. Genes of several epithelial structural proteins
including components of desmosomes and tight junctions
including PKP2, PNN and KIFC3 were found to be significantly
associated with the Pg trait (PCT5).
The Aa (PCT3) and Pg (PCT5) traits identified in this investiga-
tion have characteristics which are remarkably consistent with
the literature reports of various subsets of individuals with ag-
gressive forms of periodontal disease. The former is associated
with several genes that point to potential abnormalities in the
innate immune response and neutrophil function. Abnormal
neutrophil function that impairs chemotaxis, phagocytosis
and/or killing is a well-established risk factor or co-morbidity as-
sociated with less common, but aggressive forms of periodontal
disease (41,42). For example, one specific aggressive form of se-
vere disease is a periodontal syndrome (early onset periodontitis)
that displays advanced progression and tooth loss in young indi-
viduals (<35 years), and neutrophil chemotactic defects with ab-
normal neutrophil DKG (diacylglycerol kinase) and IP3 (inositol
triphosphate) levels (43), as discussed in Supplementary Mater-
ial, Discussion. The Aa trait (PCT3) is associated with genetic
variants of diacylglycerol kinase and inositol polyphosphate
phosphatase, which are critically involved with regulating
neutrophil function. The data from the current investigation
are based upon an older population, for which we cannot assign
an age of disease onset, and therefore the findings do not support
Table 5. Results of gene-centric association analyses of PCTs with a
continuous measure of disease severity (extent interproximal
attachment loss ≥3 mm) derived from gene-centric (MAGENTA)
orthogonal analysis (adjusting for all other PCTs except the index one)
among the Dental ARIC discovery sample (n = 975)
PCT Chr. Lead SNP Gene(s) Gene-centric P-value
1 19 rs3786949a GMFG 2.3 × 10−3
SAMD4B 2.7 × 10−3
IFNL1 (IL29) 3.3 × 10−3
LRFN1 3.5 × 10−3
2 12 rs10781645 GOLGA3 6.0 × 10−5b
1 rs4660770 KLF17 9.0 × 10−5b
3 10 rs17680667 INPP5F 1.4 × 10−4b
17 rs4148411 ABCC3 6.7 × 10−3
rs757415 CACNA1G 8.9 × 10−3
5 1 rs9426689 LUZP1 7.3 × 10−3
rs16828047 HTR1D 8.4 × 10−3
6 6 rs10484711 UBE2CBP 6.6 × 10−3
aLead SNP in the chromosome 19 locus that includes GMFG, SAMD4B, INFL1(IL29)
and LRFN1.
bDenotes gene-centric statistically significant association (the Bonferroni
multiple testing-corrected P-value threshold for testing of 80 gene associations
with the continuous measure of disease severity was 0.05/80 = 6.2 × 10−4).
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the genetic basis of this syndrome that affects younger indivi-
duals. However, they do strengthen the role of these genetic var-
iants as potential modifiers of neutrophil function and disease
expression in the presence of Aa. Further supportive evidence
of the role of genetic variants associatedwith the innate immune
response is provided by the association with genes that regulate
prostanoid and leukotriene metabolism. A locus including pros-
taglandin reductase 1, whichmetabolizes eicosanoids, was asso-
ciated with the Aa trait (PCT3). There are several reports of
abnormally elevated eicosanoids [prostaglandin E2 and leuko-
triene B4 (LTB4)] within the GCF and in tissue biopsies in aggres-
sive and early-onset periodontitis, when compared with the
more common, less severe chronic periodontitis or in periodontal
health (44–46). Abnormalities in LTB4 levels are known to modify
risk for Mycobacterium tuberculosis infection in the lung (47,48),
suggesting a key role for leukotriene metabolism in microbial re-
sistance at mucosal surfaces. The potential for abnormal IL-17
protection at the mucosal surface with missense variants of the
IL-17 adaptor protein TRAFIP3 leading to altered chemokine re-
sponse further supports the role of the potential of geneticmodu-
lation of the immune response inAa dominated dysbiosis (Fig. 4).
The second important insight is offered in the Pg trait (PCT5),
which is associated with the strong emergence of P. gingivalis, a
well-established causal organism for severe chronic periodon-
titis. We found associations of this with several intronic SNPs
of PKP2, PNN and KIFC3 that are all associated with epithelial
cell–cell adhesion, and include components of desmosomes
and tight junctions. It is not unreasonable to suggest that any
functional impairment in the epithelial boundary adjacent to
the omnipresent subgingival biofilm would have the potential
to increase the risk for disease. Interestingly, the MORN2 locus
contains a missense SNP (rs3099950) that is predicted to be a
damaging E > K variant (Polyphen-2 score 1.0). MORN2 is a phago-
some protein of macrophages that is involved with autophagy
and promotes the recruitment of LC3, an autophagy protein
also involved in phagocytosis, to M. tuberculosis-containing pha-
gosomes and subsequent maturation to degradative phagolyso-
somes (49). Thus, MORN2 structural variants would appear to
be promising candidates for further study. Clearly, these findings
alone do not suffice as proof of the genetic basis of CP, as further
replication, experiments and functional genomics will be needed
to understand the role of these candidate loci and variants. How-
ever, the findings not only highlight important candidate genes
for further investigation, but emphasize the utility of exploring
GWAS in the context of the existing microbial and inflammatory
signatures.
For decades we have recognized the tremendous heterogen-
eity of disease among patients with periodontitis in terms of in-
dividual subject’s expression of severity, prognosis and response
to therapy. These new findings provide a logical sub-classifica-
tion of disease based upon genetic and microbial-inflammatory
signatures that warrants further validation. One key limitation
Figure 4. Model of genetic and microbial patterns of periodontal disease.
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of this study is that there are no additional data sets currently
available that include clinical, microbial and genotype data to
enable replication or meta-analyses. It is clear that these loci
do not independently discriminate between clinical health
and disease and have no diagnostic utility in this context. None-
theless, the present investigation demonstrates the potential
utility of constructing a biologically informed phenotype to
identify candidate genes associated with pathogenic pathways
in disease as reflected by microbial dysbiosis and inflammatory
host response. A second limitation of this study is that the mi-
crobial characterization profiling was done using whole-genom-
ic, high stringency probes—an approach that is not an unbiased
16s sequencing analysis that would include non-cultivable spe-
cies. Although the lack of identification of non-cultivable spe-
cies represents an important limitation of this investigation
and an opportunity for future investigation, three points sug-
gest that this method does not negatively impact our current
findings. First, the six distinct microbial community structures
that are associated with disease have microbial patterns that
are consistent with previous studies that have performed 16s
sequencing methods; including studies that employ multiple
intraoral microbial sampling sites in each subject and among
subjects with health, gingivitis, chronic periodontitis and
aggressive periodontitis (50,51). Secondly, the non-cultivable
pathogens associated with disease identified to-date tend to
be associated with other organisms which are identified in the
present investigation. For example, Fretibacter fastidiosum that
belongs to the family Synergistetes and has only recently been
cultivated (52) has been associated with disease and with high
levels of Pg (53). Thus in the present study, we cannot exclude
the possibility that identifying Pg as a dominant organism of
the microbial community structure, as in PCT5, is actually a re-
flection of high levels of Fretibacter or some other non-identified
pathogenic organism that co-exists within the dysbiotic com-
munity identified by these marker organisms. Similarly, certain
PCTs have low levels of targeted bacteria and high IL-1β suggest-
ing that perhaps the inflammation and attachment loss is
attributable to microbes that were not within our panel, such
as non-cultivable bacteria or viruses. This might suggest that
some of the complex traits such as PCT2, PCT3 and PCT6 that
are associated with periodontal disease may have incomplete
phenotypic characterization to achieve statistical significance
in single-marker analyses. It is also interesting that smoking
and diabetes that are the two major risk factors for periodontal
disease aggregate with PCT2 and especially PCT6. Finally, the
identification and quantification of the microbes was performed
using whole chromosomal DNA probes that do not identify bac-
terial at a strain level and do not allow the assessment of viru-
lence of putative pathogens. Many oral pathogens possess
virulence traits that enable them to selectively emerge in the
plaque by inhibiting other microbes or preventing host clear-
ance. For example, Aa or Pg that are associated with respective
PCTs might have different bacteriocin and host-stealth proper-
ties than those Aa and Pg associated with the Socransky trait
(PCT1) or other PCTs, enabling them to emerge within the sub-
gingival biofilm.
In conclusion, the current investigation has provided new
data that suggest a genetic basis of periodontal disease defined
by microbial community structure and inflammatory character-
istics. In addition, our results highlight loci and candidate
genes for replication, functional analyses and further character-
ization as potential risk markers for subsets of individuals with
this common disease, which is associated withmicrobial dysbio-
sis at the tooth–oral mucosal interface.
Materials and Methods
Study population
Subjects were selected from four US communities to participate
in the Dental Atherosclerosis Risk in Communities (Dental
ARIC) Study (54–56). For this investigation, genotype and clinical
phenotype data were obtained from 4910 Northern European
descendants in the Dental ARIC cohort. GCF levels of IL-1β, mea-
sured at four gingival sampling areas were assayed independent-
ly to create a mean GCF-IL1® level for each subject (55). The
composition of the oral biofilmwas quantitated bymeasuring le-
vels of eight periodontal pathogens by microbe-specific DNA
probes on 975 randomly selected EA individuals from the Dental
ARIC cohort (54).
Clinical measurement and definition of periodontal
disease
The Dental ARIC ancillary study participants were seen at the
fourth visit of the ARIC Study to collect full-mouth periodontal
data and biological samples as described elsewhere (54,56). Brief-
ly, all sites on all teeth including third molars were examined
using trained and calibrated examiners with >90% agreement
(48). Measurements included number of missing teeth, gingival
index, plaque index, probing depths, attachment loss measure-
ments and bleeding upon probing. Biological samples were
collected to include serum, GCF and subgingival plaque, as previ-
ously reported. For this investigation, the plaque samples were
analyzed for levels of key periodontal pathogens and the GCF
processed for IL-1β and subgingival plaque, as described subse-
quently. We used the Centers of Disease Control (CDC) and
American Academy of Periodontology (AAP) three-level classifi-
cation. The CDC/AAP classification uses interproximal attach-
ment loss and probing depths to define disease categories as
healthy, entry and severe (57). Finally, we used extent scores for
the clinical parameters as continuous variables to describe the
level of disease and to investigate correlations with principal
components.
Quantification of periodontal organisms in plaque
samples by DNA checkerboard analyses
Levels of bacteriawithin plaque sampleswere determined as pre-
viously described (55). One plaque sample was used from each
subject, sampling the subgingival mesio-buccal site of themaxil-
lary right first molar, and assayed by DNA whole chromosomal
checkerboard for the eight periodontal pathogens. Levels of or-
ganism were expressed as counts using known microbial stan-
dards. Periodontal pathogen variables included counts of each
of the following organisms [P. gingivalis (Pg), Prevotella intermedia
(Pi), T. denticola (Td), T. forsythia (Tf, formerly Bacteroides forsythus),
C. rectus (Cr), Fusobacterium nucleatum (Fn), A. actinomycetemcomi-
tans (Aa, formerly Actinobacillus actinomycetemcomitans), P. nigres-
cens (Pn)]. Total counts reflect a summation of these targeted
pathogens for each subject.
Measurements of IL-1β in GCF
GCF was collected from the mesio-buccal region of each first
molar or, if missing, an alternate site as previously described in
detail (58). Four GCF strips were eluted and analyzed separately
for each subject. IL-1β was evaluated by enzyme-linked im-
mune-absorbent assay (ELISA) according to the manufacturer’s
instructions as described (59). GCF analyte concentration data
were pooled to provide a patient mean value in ng/mL.
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Creating PCTs using PCA
PCA was performed to create PCTs that included subject-level
periodontal disease status (CDC three-level definition), microbial
composition (counts of eight periodontal pathogens) and mean
GCF levels of IL-1β. The PROC PRINCOMP procedure was used to
derive the PCTs using SAS v9.4 (SAS Institute, Cary, NC); correl-
ation matrices with the PCTS and clinical traits were created
using SAS PROC CORR. We carried forward to GWAS only those
PCTs that were significantly associated with clinical disease
(6 out of 11). The resulting principal components comprised
the six PCTs (PCT1–6). Each PCT was characterized by a distinct
microbial community structure and the level of IL-1β that were
quantified by eigenvalues (loadings).
Genotyping, imputation and quality control
Blood collection and DNA extraction as performed at a central
ARIC laboratory in Houston, TX has been described previously
(14). Genotyping was performed using the Affymetrix Genome-
Wide Human SNP Array 6.0 chip which offers 906 600 SNP mar-
kers. The quality control procedures and SNP imputation based
onHapMap Phase II CEU build 36 is described by Divaris et al. (18).
Estimates of relatedness and population stratification in ARIC
was performed as described previously (14) to create a subset of
85 947 ‘high-quality’ SNPs that met the following criteria: MAF≥
0.1, call rate >99.5%, Hardy–Weinberg equilibrium P≥ 10−3. First-
and second-degree relativeswere identified and excluded, and 10
ancestry principal components were generated using EIGEN-
STRAT as previously described (15).
Analytical strategy
The association between individual SNPs and the six PCTs was
tested using linear regression models assuming additive allelic
effects, adjusting for age, sex, examination center and ancestry
(10 first ancestral PCs). Beta coefficients, standard errors and
P-values were estimated for each trait. We applied a multiple-
test correction assuming 1 million independent tests, resulting
to a genome-wide significance level of P < 5 × 10−8 using the
ProbABEL software (60). Q–Q plots and Manhattan plots were
generated and lambda coefficients were calculated for each com-
plex trait using custom programs (14). LocusZoom ver.1.1 (61)
was used to visualize genomic regions of interest. Coding, non-
synonymous SNPs were interrogated using PolyPhen-2 for the
prediction of potentially damagingprotein structural changes (29).
Additional online resources included tools available at the
National Center for Biotechnology Information (NCBI- http://
www.ncbi.nlm.nih.gov/) and the UCSF Genome browser v274 at
(http://genome.ucsc.edu/). Reporting of genes was based on the
‘HUGO Gene Nomenclature’ naming convention (http://www.
genenames.org). The full names and genomic locations of the
reported genes are presented in Supplementary Material,
Table S2. Individual loci were annotated using 1000 genomes,
when possible.
Gene-centric analyses of PCTs
Genome-wide association results of the six PCTs were interro-
gated for gene and gene-set enrichment using Meta-Analysis
Gene-set Enrichment of variaNT Associations (MAGENTA) using
methods previously described (15). Gene-centric association re-
sults were corrected for gene size including a 110 kb upstream
and 40 kb downstream region, number of SNPs and local linkage
disequilibrium characteristics and a multiple testing-corrected
P-value threshold of 0.05/18307 = 2.7 × 10−6 was employed.
PCT single-marker association testing with chronic
periodontitis in the larger dental ARIC cohort and
aggressive periodontitis in an independent Northern
European cohort
A true replication attempt of the PCT findings is currently im-
possible given the lack of other cohorts with ‘deep’ periodontal,
microbial and inflammatory phenotyping and genotype data.
For this reason, we examined the association of the identified
loci with clinical disease, in the larger Dental ARIC cohort and
an independent German sample as a validation attempt. This
was done to determine any potential clinical relevance of these
candidates emerging from the PCT analyses.
First, significant genes identified with MAGENTA for PCT1-6
were tested for association with periodontal disease status (ex-
tent interproximal attachment loss ≥3mm) using orthogonal
analysis. We conducted a GWA analysis as described above,
adjusting for the other 10 PCTs (excluding the index trait) using
EXTCAL3i+ as the phenotype. ThenMAGENTAwas used to obtain
gene-centric P-values for the 80 genes identified as being signifi-
cantly associatedwith the six PCTs. A stringent clinical definition
of disease as a continuous variable was selected for association
testing (EXTCAL3i+), using a Bonferroni corrected P-value of
0.05/80 = 0.00062 as the statistical significance threshold. This al-
lowed for the testing of candidate genes in the context of their
index PCT, reflecting distinct microbial community structures
and levels of IL-1β. The results of this analytical step should be
interpreted with caution as there is the potential for false-
positive findings due to collinearity. To examine for possible is-
sues of collinearity (due to the inclusion of PCTs as covariates),
we obtained VIFs via the SAS PROC REG ‘/VIF’ option for the
models used to produce Table 5. Although there is no consensus
with critical VIF values to denote collinearity, VIF >10 is generally
considered indicative of serious collinearity (37).
Furthermore, we obtained association results (betas and P-va-
lues) with aggressive periodontitis of SNPs highlighted in our sin-
gle-marker and gene-centric analyses from an independent
North andWest German sample that has been reported by Schae-
fer and colleagues (32–35). This sample included 717 aggressive
periodontitis cases [AgP; 302 males, 415 females, 355 smokers
(155 unknown)] (33) and 4213 controls [2018 males, 2191 females
(four unknown)], 2239 smokers (161 unknown) from the FOCUS
(Food Chain Plus) (33), DOGS (Dortmunder Gesundheitsstudie)
(34) and HNR1-3 (Heinz Nixdorf Recall Studie) (35) cohorts.
German participants were genotyped on an IScan system with
HumanOmni BeadChips (Illumina) as recently described (32). A
description of this validation sample is given in Supplementary
Material, Tables S6 and S7, and in Supplementary Material,
Methods. Evidence of SNP association validation in the German
cohort was determined by (i) multiple testing-corrected statistic-
al significance (P < 0.00135); (ii) nominal statistical significance;
(iii) directional consistency, accounting for testing of 37 SNPs.
Supplementary Material
Supplementary Material is available at HMG online.
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Wiśniewska, J., Serrano-Fernandez, P., Mirecka, A., Paszkows-
ka-Szczur, K., Lubinski, J., Krysztoforska, L. et al. (2014) Com-
mon variants of ZNF750, RPTOR and TRAF3IP2 genes and
psoriasis risk. Arch. Dermatol. Res., 306, 231–238.
40. Ciccacci, C., Biancone, L., Di Fusco, D., Ranieri, M., Condino,
G., Giardina, E., Onali, S., Lepre, T., Pallone, F., Novelli, G.
et al. (2013) TRAF3IP2 gene is associated with cutaneous ex-
traintestinal manifestations in inflammatory bowel disease.
J. Crohns. Colitis, 7, 44–52.
41. Fredman, G., Oh, S.F., Ayilavarapu, S., Hasturk, H., Serhan, C.N.
and Van Dyke, T.E. (2011) Impaired phagocytosis in localized
aggressive periodontitis: rescue by Resolvin E1. PLoS One, 6,
e24422.
42. Khocht, A. and Albandar, J.M. (2014) Aggressive forms of peri-
odontitis secondary to systemic disorders. Periodontology
2000, 65, 134–148.
43. Tyagi, S.R., Uhlinger, D.J., Lambeth, J.D., Champagne, C. and
Van Dyke, T.E. (1992) Altered diacylglycerol level and metab-
olism in neutrophils from patients with localized juvenile
periodontitis. Infect. Immun., 60, 2481–2487.
44. Emingil, G., Çinarcik, C., Baylas, H., Çoker, I. andHüseyinov, A.
(2001) Levels of leukotriene B4 in gingival crevicular fluid and
gingival tissue in specific periodontal diseases. J. Periodontol.,
72, 1025–1031.
45. Kantarci, A., Oyaizu, K. and Van Dyke, T.E. (2003) Neutrophil-
mediated tissue injury in periodontal disease pathogenesis:
findings from localized aggressive periodontitis. J. Periodontol.,
74, 66–75.
46. Pradeep, A.R., Manjunath, S.G., Swati, P.P., Shikha, C. and
Sujatha, P.B. (2007) Gingival crevicular fluid levels of leuko-
triene B4 in periodontal health and disease. J. Periodontol.,
78, 2325–2330.
47. el-Ahmady, O., Mansour, M., Zoeir, H. and Mansour, O. (1997)
Elevated concentrations of interleukins and leukotriene
in response to Mycobacterium tuberculosis infection. Ann.
Clin. Biochem., 34, 160–164.
48. Tobin, D.M., Roca, F.J., Ray, J.P., Ko, D.C. and Ramakrishnan, L.
(2013) An enzyme that inactivates the inflammatory medi-
ator leukotriene b4 restricts mycobacterial infection. PLoS
One, 8, e67828.
49. Abnave, P., Mottola, G., Gimenez, G., Boucherit, N., Trouplin,
V., Torre, C., Conti, F., Ben Amara, A., Lepolard, C., Djian, B.
et al. (2014) Screening in planarians identifies MORN2
as a key component in LC3-associated phagocytosis
2128
Human Molecular Genetics, 2016, Vol. 25, No. 10 | 
and resistance to bacterial infection.Cell HostMicrobe, 16, 338–
350.
50. Liu, B., Faller, L.L., Klitgord, N., Mazumdar, V., Ghodsi, M.,
Sommer, D., Gibbons, T.R., Treangen, T.J., Chang, Y., Li, S.
et al. (2012) Deep sequencing of the oral microbiome reveals
signatures of periodontal disease. PLoS One, 7, e37919.
51. Duran-Pinedo, A.E., Chen, T., Teles, R., Starr, J.R., Wang, X.,
Krishnan, K. and Frias-Lopez, J. (2014) Community-wide tran-
scriptome of the oral microbiome in subjects with and with-
out periodontitis. ISME J., 8, 1659–1672.
52. Vartoukian, S.R., Downes, J., Palmer, R.M. andWade,W.G. (2013)
Fretibacterium fastidiosumgen. nov., sp.nov., isolated from the
human oral cavity. Int. J. Syst. Evol. Microbiol., 63, 458–463.
53. Wade, W.G. (2013) Characterisation of the human oral micro-
biome. J. Oral Biosci., 55, 143–148.
54. Beck, J.D., Elter, J.R., Heiss, G., Couper, D., Mauriello, S.M. and
Offenbacher, S. (2001) Relationship of periodontal disease to
carotid artery intima–media wall thickness: the atheroscler-
osis risk in communities (ARIC) study. Arter. Thromb. Vasc.
Biol., 21, 1816–1822.
55. Offenbacher, S., Barros, S.P., Singer, R.E.,Moss, K.,Williams, R.C.
and Beck, J.D. (2007) Periodontal disease at the biofilm–gingival
interface. J. Periodontol., 78, 1911–1925.
56. Elter, J.R., Champagne, C.M.E., Offenbacher, S. and Beck, J.D.
(2004) Relationship of periodontal disease and tooth loss
to prevalence of coronary heart disease. J. Periodontol., 75,
782–790.
57. Page, R.C. and Eke, P.I. (2007) Case definitions for use in popu-
lation-based surveillance of periodontitis. J. Periodontol., 78,
1387–1399.
58. Champagne, C.M.E., Buchanan, W., Reddy, M.S., Preisser, J.S.,
Beck, J.D. and Offenbacher, S. (2003) Potential for gingival
crevice fluid measures as predictors of risk for periodontal
diseases. Periodontology 2000, 31, 167–180.
59. Offenbacher, S., Lin, D., Strauss, R., McKaig, R., Irving, J.,
Barros, S.P., Moss, K., Barrow, D., Hefti, A. and Beck, J.D.
(2006) Effects of periodontal therapy during pregnancy
on periodontal status, biologic parameters, and pregnancy
outcomes: a pilot study. J. Periodontol., 77, 2011–2024.
60. Aulchenko, Y.S., Struchalin, M.V. and van Duijn, C.M. (2010)
ProbABEL package for genome-wide association analysis of
imputed data. BMC Bioinform., 11, 134–144.
61. Pruim, R.J.,Welch, R.P., Sanna, S., Teslovich, T.M., Chines, P.S.,
Gliedt, T.P., Boehnke, M., Abecasis, G.R. and Willer, C.J. (2010)
LocusZoom: regional visualization of genome-wide as-
sociation scan results. Bioinformatics, 26, 2336–2337.
2129
